D. E. Shaw & Co., Inc. Orchard Therapeutics PLC Transaction History

D. E. Shaw & Co., Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.42 - $0.78 $95,033 - $176,491	226,271 New	226,271 $132,000
Q3 2020 Nov 16, 2020	SELL	$4.11 - $6.45 $232,215 - $364,425	-56,500 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.75 - $11.99 $104,374 - $217,642	18,152 Added 47.33%	56,500 $339,000
Q1 2020 May 15, 2020	BUY	$5.65 - $15.71 $134,294 - $373,410	23,769 Added 163.04%	38,348 $289,000
Q4 2019 Feb 14, 2020	BUY	$10.15 - $15.58 $147,976 - $227,140	14,579 New	14,579 $200,000
Q3 2019 Nov 14, 2019	SELL	$11.88 - $16.72 $200,783 - $282,584	-16,901 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.2 - $20.63 $223,093 - $348,667	16,901 New	16,901 $236,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.